247 related articles for article (PubMed ID: 26129771)
1. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J
Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771
[TBL] [Abstract][Full Text] [Related]
2. Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of alpha-synuclein through different pathways.
Almandoz-Gil L; Welander H; Ihse E; Khoonsari PE; Musunuri S; Lendel C; Sigvardson J; Karlsson M; Ingelsson M; Kultima K; Bergström J
Free Radic Biol Med; 2017 Sep; 110():421-431. PubMed ID: 28690195
[TBL] [Abstract][Full Text] [Related]
3. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties.
Näsström T; Fagerqvist T; Barbu M; Karlsson M; Nikolajeff F; Kasrayan A; Ekberg M; Lannfelt L; Ingelsson M; Bergström J
Free Radic Biol Med; 2011 Feb; 50(3):428-37. PubMed ID: 21130160
[TBL] [Abstract][Full Text] [Related]
4. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation.
Qin Z; Hu D; Han S; Reaney SH; Di Monte DA; Fink AL
J Biol Chem; 2007 Feb; 282(8):5862-70. PubMed ID: 17189262
[TBL] [Abstract][Full Text] [Related]
5. The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers.
Näsström T; Wahlberg T; Karlsson M; Nikolajeff F; Lannfelt L; Ingelsson M; Bergström J
Biochem Biophys Res Commun; 2009 Jan; 378(4):872-6. PubMed ID: 19070597
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
[TBL] [Abstract][Full Text] [Related]
7. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein.
Bae EJ; Ho DH; Park E; Jung JW; Cho K; Hong JH; Lee HJ; Kim KP; Lee SJ
Antioxid Redox Signal; 2013 Mar; 18(7):770-83. PubMed ID: 22867050
[TBL] [Abstract][Full Text] [Related]
8. Generation and Characterization of Stable α-Synuclein Oligomers.
Almandoz-Gil L; Ingelsson M; Bergström J
Methods Mol Biol; 2018; 1779():61-71. PubMed ID: 29886527
[TBL] [Abstract][Full Text] [Related]
9. Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo.
Fagerqvist T; Näsström T; Ihse E; Lindström V; Sahlin C; Tucker SM; Kasaryan A; Karlsson M; Nikolajeff F; Schell H; Outeiro TF; Kahle PJ; Lannfelt L; Ingelsson M; Bergström J
Amyloid; 2013 Dec; 20(4):233-44. PubMed ID: 24053224
[TBL] [Abstract][Full Text] [Related]
10. Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.
Vaikath N; Sudhakaran I; Abdi I; Gupta V; Majbour N; Ghanem S; Abdesselem H; Vekrellis K; El-Agnaf O
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498957
[TBL] [Abstract][Full Text] [Related]
11. Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.
Hong DP; Fink AL; Uversky VN
J Mol Biol; 2008 Oct; 383(1):214-23. PubMed ID: 18775438
[TBL] [Abstract][Full Text] [Related]
12. Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications.
Andersen C; Grønnemose AL; Pedersen JN; Nowak JS; Christiansen G; Nielsen J; Mulder FAA; Otzen DE; Jørgensen TJD
Biochemistry; 2021 Nov; 60(47):3644-3658. PubMed ID: 34730940
[TBL] [Abstract][Full Text] [Related]
13. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the non-fibrillar α-synuclein oligomers.
Hong DP; Han S; Fink AL; Uversky VN
Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207
[TBL] [Abstract][Full Text] [Related]
15. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals.
Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM
Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470
[TBL] [Abstract][Full Text] [Related]
16. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers.
Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040
[TBL] [Abstract][Full Text] [Related]
17. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
[TBL] [Abstract][Full Text] [Related]
18. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
[TBL] [Abstract][Full Text] [Related]
19. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
[TBL] [Abstract][Full Text] [Related]
20. A Capped Peptide of the Aggregation Prone NAC 71-82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations.
Näsström T; Ådén J; Shibata F; Andersson PO; Karlsson BCG
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
